Agios Pharmaceuticals Inc (AGIO)

Operating Income Growth

0.54%

TTM · Period ending:

AGIO logo

AGIO Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported0.54%
AGIO TTM Operating Income YoY % (-69.10% → 0.54%)
High-resolution chart · PNG

AGIO operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Agios Pharmaceuticals Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
0.5436%
-8.0024%
-10.8976%
-16.8594%
-13.941%
-12.0495%
-8.7487%
-5.8783%
-8.1394%
-3.8125%
-0.6272%
2.6146%
5.1142%
2.5315%
-2.8088%
-7.8347%
-8.0953%
-6.6375%
-19.6961%
-11.0365%
-4.829%
2.1148%
25.8446%
20.9032%
14.3747%
-1.6647%
-17.6159%
-16.9843%
-21.051%
-5.2309%
-12.9943%
-23.6676%
-23.3116%
-42.2688%
-59.6109%
-56.16%
-68.8397%
-78.2931%
-69.3218%
-76.4785%
-165.3146%
-191.4272%
-119.2747%
-163.6451%
-12.8363%
-6.625%
-39.2202%
-19.6451%
-98.4069%
-78.0796%
-69.1006%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.